Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast CancerJessica J. Tao, Maurizio Scaltriti, Pau Castel et al.|Science Signaling|2014Cited by 166
Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cellsValentí Gómez, Tony Ng|Science Signaling|2020Cited by 74
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphomaPier Luigi Zinzani, F. Morschhauser, Coralith García et al.|Haematologica|2016Cited by 48
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in transJosé M. Vicencio, Tony Ng|Cell Death and Disease|2022Cited by 30
Chemotherapeutic regulation of the ROS/MondoA-dependent TXNIP/GDF15 axis; and derivation of a new organoid metric as a predictive biomarkerJinhai Deng, Tony Ng|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0